Literature DB >> 1740317

Molecular characterization of beta-thalassemia in Czechoslovakia.

K Indrak1, V Brabec, J Indrakova, L Chrobak, A Sakalova, M Jarosova, J Cermak, Y J Fei, F Kutlar, Y C Gu.   

Abstract

We have identified different beta-thalassemia mutations in 93 members of 34 families of Czech or Slovakian descent using gene amplification, hybridization with specific 32P-labeled oligonucleotide probes, sequencing of amplified DNA, and gene mapping. The G----A mutation at IVS-I-1 was found in 18 families; other Mediterranean mutations were IVS-II-1 (G----A), IVS-II-745 (C----G), IVS-I-110 (G----A), and codon 39 (C----T); these were present in 9 additional families. The G----T mutation at codon 121, known to cause Heinz-body beta-thalassemia, was present in 3 families, and the frameshift at codons 82/83 (-G), first described in the Azerbaijanian population, in 2 families. A newly discovered allele was a frameshift at codons 38/39 (-C). One beta-thalassemia allele was incompletely characterized. We observed in 2 families a T----C mutation at position +96 UTR (untranslated region) relative to the termination codon; this mutation likely is a rare polymorphism. alpha-Thalassemia was rare; only one person carried the -alpha 3.7 heterozygosity, and one other had a yet to be identified alpha-thalassemia-1, while seven had the alpha alpha alpha anti 3.7 triplication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740317     DOI: 10.1007/bf00215673

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  29 in total

1.  A novel frameshift mutation causing beta-thalassaemia in Azerbaijan.

Authors:  E I Schwartz; A A Gol'tsov; O K Kaboev; A A Alexeev; V L Surin; A V Lukianenko; S V Vinogradov
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

2.  Fetal hemoglobin in normal adults and beta-thalassemia heterozygotes.

Authors:  A Kutlar; F Kutlar; L G Gu; S M Mayson; T H Huisman
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

3.  Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family.

Authors:  K Indrak; J Indrakova; F Kutlar; D Pospisilova; I Sulovska; E Baysal; T H Huisman
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

4.  Hb Köln or alpha 2 beta 2(98)(FG5)Val----Met in a Czechoslovakian family.

Authors:  K Indrak; V Brabec; J B Wilson; B B Webber; T H Huisman
Journal:  Hemoglobin       Date:  1991       Impact factor: 0.849

5.  One form of inclusion body beta-thalassemia is due to a GAA----TAA mutation at codon 121 of the beta chain.

Authors:  Y J Fei; T A Stoming; A Kutlar; T H Huisman; G Stamatoyannopoulos
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

6.  High-performance liquid chromatographic separation of human haemoglobins. Simultaneous quantitation of foetal and glycated haemoglobins.

Authors:  E Bisse; H Wieland
Journal:  J Chromatogr       Date:  1988-12-29

7.  [Beta thalassemia in Czech families].

Authors:  V Brabec; J Borová; H Fortová; O Hrodek; J Neuwirt; R Neuwirtová; E Syrist'ová
Journal:  Vnitr Lek       Date:  1988-10

8.  The rare alpha-thalassemia-1 of blacks is a zeta alpha-thalassemia-1 associated with deletion of all alpha- and zeta-globin genes.

Authors:  A E Felice; M P Cleek; K McKie; V McKie; T H Huisman
Journal:  Blood       Date:  1984-05       Impact factor: 22.113

9.  Characterization of three types of beta zero-thalassemia resulting from a partial deletion of the beta-globin gene.

Authors:  J M Gonzalez-Redondo; C Kattamis; T H Huisman
Journal:  Hemoglobin       Date:  1989       Impact factor: 0.849

10.  Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States.

Authors:  J M Gonzalez-Redondo; T A Stoming; K D Lanclos; Y C Gu; A Kutlar; F Kutlar; T Nakatsuji; B Deng; I S Han; V C McKie
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

View more
  8 in total

1.  Molecular characterization of beta-thalassemia in Hungary.

Authors:  B Ringelhann; J G Szelenyi; M Horanyi; M Svobodova; V Divoky; K Indrak; S Hollân; A Marosi; M Laub; T H Huisman
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

2.  The T-->C mutation at position +96 of the untranslated region 3' to the terminating codon of the beta-globin gene is a rare polymorphism that does not cause a beta-thalassemia as previously ascribed.

Authors:  V Divoky; E Baysal; R Oner; M A Cürük; E L Walker; K Indrak; T H Huisman
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

3.  The great heterogeneity of thalassemia molecular defects in Sicily.

Authors:  A Giambona; P Lo Gioco; M Marino; I Abate; R Di Marzo; M Renda; F Di Trapani; F Messana; S Siciliano; P Rigano
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

4.  β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.

Authors:  Lucie Lanikova; Jana Kucerova; Karel Indrak; Martina Divoka; Jean-Pierre Issa; Thalia Papayannopoulou; Josef T Prchal; Vladimir Divoky
Journal:  Hum Mutat       Date:  2013-08-13       Impact factor: 4.878

5.  Molecular characterization of beta-thalassemia in Azerbaijan.

Authors:  M A Cürük; G T Yüregir; C D Asadov; T Dadasova; L H Gu; E Baysal; Y C Gu; M L Ribeiro; T H Huisman
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

6.  Sickle cell anemia, sickle cell beta-thalassemia, and thalassemia major in Albania: characterization of mutations.

Authors:  E Boletini; M Svobodova; V Divoky; E Baysal; M A Cürük; A J Dimovski; R Liang; A D Adekile; T H Huisman
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

7.  Molecular heterogeneity of β-thalassemia variants in the Eastern region of Morocco.

Authors:  Ihab Belmokhtar; Saida Lhousni; Mounia Elidrissi Errahhali; Ayad Ghanam; Manal Elidrissi Errahhali; Zaina Sidqi; Meryem Ouarzane; Majida Charif; Mohammed Bellaoui; Redouane Boulouiz; Noufissa Benajiba
Journal:  Mol Genet Genomic Med       Date:  2022-05-26       Impact factor: 2.473

8.  Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.

Authors:  Adekunle Adekile; Nagihan Akbulut-Jeradi; Rasha Al Khaldi; Maria Jinky Fernandez; Jalaja Sukumaran
Journal:  J Pers Med       Date:  2021-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.